Cover Image

Potential role for neutralizing antibodies in HIV-1 infection

Saved in:

Bibliographic Details
Main Author:	J. Mascola (Author)
Format:	Book
Published:	Elsevier, 2015-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Broadly neutralizing antibodies in HIV-1 treatment and prevention
by: Rajesh Kumar, et al.
Published: (2018)

PP 8.8 - 00129 Antibody mediated killing of HIV-1 infected cells with glycoengineered broadly neutralizing antibodies
by: S. De Taeye, et al.
Published: (2022)

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants
by: Yunda Huang, et al.
Published: (2022)

7 Presence of HIV-1C broadly neutralizing antibodies in pregnancy and at delivery
by: T. Mduluza, et al.
Published: (2016)

Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies
by: Gwo-Yu Chuang, et al.
Published: (2020)

Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic
by: David A. Spencer, et al.
Published: (2021)

HIV-Induced Damage of B Cells and Production of HIV Neutralizing Antibodies
by: Francesca Chiodi
Published: (2018)

Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV
by: Sarah B. Lloyd, et al.
Published: (2017)

Why Does the Molecular Structure of Broadly Neutralizing Monoclonal Antibodies Isolated from Individuals Infected with HIV-1 not Inform the Rational Design of an HIV-1 Vaccine?
by: Marc H V Van Regenmortel
Published: (2015)

Diverse HIV-1 escape pathways from broadly neutralizing antibody PGDM1400 in humanized mice
by: Yme U. van der Velden, et al.
Published: (2020)

Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain
by: Young D. Kwon, et al.
Published: (2023)

Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines
by: Qianqian Li, et al.
Published: (2017)

To prescreen or not to prescreen for broadly neutralizing antibody sensitivity in HIV cure-related trials
by: Hursch Patel, et al.
Published: (2023)

Evaluation of cross-neutralizing antibodies in children infected with omicron sub-variants
by: Weiyu Peng, et al.
Published: (2023)

Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses
by: S. Stenler, et al.
Published: (2017)

Neutralizing antibodies for orthobunyaviruses in Pantanal, Brazil.
by: Alex Pauvolid-Corrêa, et al.
Published: (2017)

Targeting HIV reservoir by DART molecules that recruit T cells to HIV Env expressing cells: comparison of HIV arms derived from broadly reactive neutralizing or non-neutralizing anti-Env antibodies
by: J.L. Nordstrom, et al.
Published: (2015)

Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab
by: Angela J. Okragly, et al.
Published: (2023)

THE PROBLEM OF NEUTRALIZING ANTIBODIES IN MANAGEMENT OF MULTIPLE SCLEROSIS
by: B.I. Bursagova, et al.
Published: (2011)

THE PROBLEM OF NEUTRALIZING ANTIBODIES IN MANAGEMENT OF MULTIPLE SCLEROSIS
by: B.I. Bursagova, et al.
Published: (2011)

OA2-4 Enhancing HIV-1 virion tethering by BST2/tetherin sensitizes productively and latently infected T cells to ADCC mediated by broadly neutralizing anti-HIV antibodies
by: T.N.Q. Pham, et al.
Published: (2016)

Establishment of the 1st Chinese national standard for CA6 neutralizing antibody
by: Yiping Wang, et al.
Published: (2023)

Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies.
by: Darunee Buddhari, et al.
Published: (2014)

Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
by: Zeqi Zhou, et al.
Published: (2021)

Effector mechanisms of influenza-specific antibodies: neutralization and beyond
by: Federica Sicca, et al.
Published: (2018)

Neutralizing dengue antibody in pregnant Thai women and cord blood.
by: Kriangsak Khamim, et al.
Published: (2015)

Aptamer-facilitated Protection of Oncolytic Virus from Neutralizing Antibodies
by: Darija Muharemagic, et al.
Published: (2014)

Neutralizing and enhancing antibodies against SARS-CoV-2
by: Yafei Liu, et al.
Published: (2022)

Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection
by: Alessandro Manenti, et al.
Published: (2023)

Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development.
by: Mei-Liang Huang, et al.
Published: (2013)

Development and optimization of a sensitive pseudovirus-based assay for HIV-1 neutralizing antibodies detection using A3R5 cells
by: Qingqing Chen, et al.
Published: (2018)

A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge
by: Ruixiao Du, et al.
Published: (2019)

Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.
by: Yadunanda Budigi, et al.
Published: (2018)

Postdose 3 G1 serum neutralizing antibody as correlate of protection for pentavalent rotavirus vaccine
by: G. Frank Liu, et al.
Published: (2017)

HIV-1 sequences with more predicted glycans in acute infection were associated with the development of higher neutralization breadth
by: Melanie Merbah, et al.
Published: (2018)

High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.
by: In-Kyu Yoon, et al.
Published: (2015)

The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV
by: Lori M. Cullen, et al.
Published: (2017)

Visaghna herbs and metals as neutralizing antibodies in the prevention and treatment of infection by severe acute respiratory syndrome-Coronavirus-2
by: Manoj Kumar Dash, et al.
Published: (2020)

Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
by: Taichi Kuramochi, et al.
Published: (2022)

Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin
by: Kexuan Cheng, et al.
Published: (2024)